South Korea clears VUNO’s private ECG machine


Share post:

Medical AI firm VUNO has obtained the South Korean Ministry of Meals and Drug Security’s clearance for its private ECG machine.

Referred to as Hativ Professional, the moveable medical machine merely measures a person’s coronary heart charge and sends this information by means of a linked cell phone app. 


VUNO has been providing a spread of medical AI options for docs and well being amenities. Following this newest authorities certification, VUNO can lastly transfer in the direction of providing AI medical gadgets to shoppers. 

With the MFDS clearance, the corporate plans to quickly launch its built-in well being administration model Hativ, that includes AI-powered dwelling medical gadgets that help shoppers’ day by day well being administration and early prognosis of continual ailments. 

VUNO continues to strengthen its medical AI enterprise based mostly on ECG information, which the corporate claims have “excessive potential as a biomarker for numerous cardiovascular ailments”. In South Korea, CVDs are the second main explanation for demise after most cancers with instances rising every year because of an ageing inhabitants.

“By our ECG data-based medical AI challenge, we’ll do our greatest to scale back mortality from heart problems and contribute to preventive remedy – the long run course of medical care,” mentioned VUNO CEO Lee Ye Ha.

Sooner or later, VUNO plans to launch extra dwelling AI medical gadgets for detecting main coronary heart ailments.


In current months, VUNO has been accumulating a number of regulatory approvals to market its AI medical options in South Korea and the remainder of Asia-Pacific.

In March, VUNO secured the South Korean authorities’s approval for VUNO Med LungQuant, an AI-based lung CT quantification answer for the exact analysis and screening of lung ailments. Final 12 months, it additionally obtained an MFDS clearance for VUNO Med DeepCARS, a medical machine that makes use of AI to analyse an individual’s danger for cardiac arrest.

Within the first half of the 12 months, the corporate additionally obtained market approvals in Thailand, Saudi Arabia, and Malaysia for its different VUNO Med choices.

Supply hyperlink


Please enter your comment!
Please enter your name here


Related articles